Cargando…

Comparison of matrix metalloproteinase 9 and 14 levels in vitreous samples in diabetic and non-diabetic patients: a case control study

BACKGROUND: MMP-9 plays a prominent role in inflammation and MMP-14 take part in angiogenesis. The objective of this study is to compare MMP-9 and MMP-14 levels between diabetic and non-diabetic patients. METHODS: The patients who scheduled for pars plana vitrectomy were included in our study. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ünal, A., Baykal, O., Öztürk, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210686/ https://www.ncbi.nlm.nih.gov/pubmed/35729613 http://dx.doi.org/10.1186/s40942-022-00394-0

Ejemplares similares

Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2013)

Sequential in-office vitreous aspirates demonstrate vitreous matrix metalloproteinase 9 levels correlate with the amount of subretinal fluid in eyes with wet age-related macular degeneration
por: Ecker, Stephanie M., et al.
Publicado: (2012)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2018)

Intraocular matrix metalloproteinase 2 and 9 in patients with diabetes mellitus with and without diabetic retinopathy
por: Kłysik, Anna B., et al.
Publicado: (2010)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Regulation of Matrix Metalloproteinase-9 by Epigenetic Modifications and the Development of Diabetic Retinopathy
por: Zhong, Qing, et al.
Publicado: (2013)

Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics
por: Prathipati, Priyanka, et al.
Publicado: (2016)

Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy
por: Kowluru, Renu A., et al.
Publicado: (2016)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus
por: Yürük Yıldırım, Zeynep, et al.
Publicado: (2019)

Matrix Metalloproteinase-9 −1562C/T Gene Polymorphism Is Associated with Diabetic Nephropathy
por: Feng, Shufen, et al.
Publicado: (2016)

Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients
por: Tsai, Teresa, et al.
Publicado: (2018)

Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II
por: Vitlianova, Katerina, et al.
Publicado: (2015)

Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia
por: Lewandowski, Krzysztof C., et al.
Publicado: (2011)

Matrix metalloproteinases in subjects with type 1 diabetes
por: Gharagozlian, Sedegheh, et al.
Publicado: (2009)

Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers
por: Liu, Yu, et al.
Publicado: (2009)

Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes
por: Duraisamy, Arul J., et al.
Publicado: (2017)

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
por: CHEN, SU-ZUAN, et al.
Publicado: (2015)

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
por: Lorente, Leonardo, et al.
Publicado: (2009)

Serum and Vitreous Levels of Visfatin in Patients with Diabetic Retinopathy
por: Wang, Yongqiang, et al.
Publicado: (2014)

Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy
por: Loporchio, Dean F., et al.
Publicado: (2021)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Early vitrectomy in eyes with non-diabetic vitreous hemorrhage
por: Foo, Edward, et al.
Publicado: (2022)

Expression of matrix metalloproteinases-8 and -9 and their tissue inhibitor in the condyles of diabetic rats with mandibular advancement
por: ZHONG, XIAOHUAN, et al.
Publicado: (2014)

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
por: Waas, E T, et al.
Publicado: (2002)

Serum Level of Matrix Metalloproteinase-9 in Patients with Salivary Gland Tumor
por: Mardani, Maryam, et al.
Publicado: (2014)

Plasma Levels of Matrix Metalloproteinase-9 in Children With Chronic Spontaneous Urticaria
por: Dilek, Fatih, et al.
Publicado: (2016)

Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
por: Valente, Flavia Mariana, et al.
Publicado: (2020)

Matrix metalloproteinase 14 is required for fibrous tissue expansion
por: Taylor, Susan H, et al.
Publicado: (2015)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters
por: Mesquita, Joana, et al.
Publicado: (2017)

Puerarin Attenuated Early Diabetic Kidney Injury through Down-Regulation of Matrix Metalloproteinase 9 in Streptozotocin-Induced Diabetic Rats
por: Zhong, Yifei, et al.
Publicado: (2014)

Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications
por: Zhang, Zhongwen, et al.
Publicado: (2015)

Up-regulation of matrix metalloproteinases-9 in the kidneys of diabetic rats and the association with neutrophil gelatinase-associated lipocalin
por: Yang, Huayu, et al.
Publicado: (2021)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_lduktat6571qd579fkubpuibj0